Osteocalcin, ovarian senescence, and brain health

Marc Schatz, Sharnikha Saravanan, Nathan D. d'Adesky, Helen Bramlett, Miguel A. Perez-Pinzon, Ami P. Raval

Research output: Contribution to journalReview article

Abstract

Menopause, an inevitable event in a woman's life, significantly increases risk of bone resorption and diseases such as Alzheimer's, vascular dementia, cardiac arrest, and stroke. The sole role of bones, as traditionally regarded, is to provide structural support for skeletal muscles and allow for ambulation, however this concept is becoming quickly outdated. New literature has emerged that suggests the bone cell-derived hormone osteocalcin (OCN) plays a pivotal role in cognition. OCN levels are correlated with bone mass density and bone turnover, and thus are strongly influenced by the changes associated with menopause. The goal of the current review is to discuss potential gaps in our knowledge of OCN and cognition, discrepancies in methods of OCN quantification, and therapies to enhance circulating OCN. A discussion on implementing exercise or low frequency vibration interventions at the menopausal transition to reduce risk and severity of neurological diseases and associated cognitive decline is included.

Original languageEnglish (US)
Article number100861
JournalFrontiers in Neuroendocrinology
Volume59
DOIs
StatePublished - Oct 2020

Keywords

  • Alzheimer's disease
  • Frailty
  • Menopause
  • Physical exercise
  • Stroke
  • Vascular dementia
  • Whole body vibration

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems

Fingerprint Dive into the research topics of 'Osteocalcin, ovarian senescence, and brain health'. Together they form a unique fingerprint.

  • Cite this